1. The Innate Immune Sensor Sting Can Augment or Ameliorate Graft-Versus-Host Disease Dependent on the Genetic Disparity between Donors and Recipients 
Cameron S. Bader, Henry Barreras, Casey O. Lightbourn, Sabrina Copsel, Jeonghyun Ahn, Glen N. Barber, Robert B. Levy 
Biology of Blood and Marrow Transplantation 
Volume 24, Issue 3, Pages S176-S177 (March 2018)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
The innate immune sensor STING can worsen or ameliorate GVHD dependent on the donor/recipient genetic disparity and kinetics of HSCT. (A) Survival of B6-WT or B6-STING-/- recipients after 11.5 Gy irradiation on day-1 and transplant with 7 × 106 BM cells and ~4 × 106 LN cells (normalized to 1.7 × 106 T cells) or (B) after 10.5 Gy irradiation on day 0 and transplant with 7 × 106 BM cells and ~4 × 106 LN cells (normalized to 1.8 × 106 T cells) from BALB/c donors. (C) Fold induction of IFNβ, TNFα and IL-6 RNA from B6-WT or B6-STING-/- recipient colon tissue 48 hrs. after 8.5 Gy irradiation on day 0 and transplant with 10 × 106 BM cells and ~2.5 × 106 spleen cells (normalized to 8 × 105 T cells) from LP/J donors. (D) GVHD clinical score of B6-WT or B6-STING-/- recipients after 10.5 Gy irradiation on day 0 and transplant with 7 × 106 BM cells and ~24 × 106 spleen + peripheral LN cells (normalized to 2 × 106 CD8+ T cells) from C3H.SW donors. (E) Survival of B6-WT and B6-STING-/- recipients transplant as in (D) with IP injection of DMXAA (25 mg/kg) or vehicle (5% NaHCO3) at the time of irradiation. All data show mean + SEM. Statistical significance determined using unpaired two-tailed t-test or log-rank test. *** p < .001, ** p < .01, * p < .05.
Biology of Blood and Marrow Transplantation  , S176-S177DOI: ( /j.bbmt )
Copyright © Terms and Conditions